Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.22 EUR
−5.98 M EUR
0.00 EUR
2.59 M
About MEDICUS PHARMA LTD.
Sector
Industry
CEO
Raza Bokhari
Website
Headquarters
Toronto
Founded
2008
FIGI
BBG01L0R2FF0
Medicus Pharma Ltd. is a clinical stage, multi-strategy holding company, which engages in investing in novel life sciences and bio-technology companies. It focuses on identifying, acquiring, and advancing relatively de-risked clinical stage assets through clinical development and commercialization. The company was founded on April 30, 2008 and is headquartered in Toronto, Canada.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange MEDICUS PHARMA LTD. stocks are traded under the ticker N460.
We've gathered analysts' opinions on MEDICUS PHARMA LTD. future price: according to them, N460 price has a max estimate of 11.59 EUR and a min estimate of 3.77 EUR. Watch N460 chart and read a more detailed MEDICUS PHARMA LTD. stock forecast: see what analysts think of MEDICUS PHARMA LTD. and suggest that you do with its stocks.
N460 reached its all-time high on Mar 17, 2008 with the price of 30.32 EUR, and its all-time low was 2.20 EUR and was reached on Dec 3, 2024. View more price dynamics on N460 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track MEDICUS PHARMA LTD. financials in yearly and quarterly reports right on TradingView.
MEDICUS PHARMA LTD. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
N460 earnings for the last quarter are −0.29 EUR per share, whereas the estimation was −0.21 EUR resulting in a −42.30% surprise. The estimated earnings for the next quarter are −0.26 EUR per share. See more details about MEDICUS PHARMA LTD. earnings.
MEDICUS PHARMA LTD. revenue for the last quarter amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
N460 net income for the last quarter is −2.68 M EUR, while the quarter before that showed −3.86 M EUR of net income which accounts for 30.50% change. Track more MEDICUS PHARMA LTD. financial stats to get the full picture.
No, N460 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, N460 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDICUS PHARMA LTD. stock right from TradingView charts — choose your broker and connect to your account.